EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Overview

Notification made after deadline
Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)

1. Issuer: Marinomed Biotech AG

2. Reason for the notification:
Acquisition or disposal of voting rights

3. Person subject to notification obligation
Acting in concert agreement (Sec. 133 No. 1 BörseG 2018)

Name: Conseq Invest Akcie Nové Evropy
City: Dublin
Country: Ireland

Name: Conseq globální akciový úcastnický fond
City: Prague
Country: Czech Republic

4. Name of shareholder(s):

5. Date on which the threshold was crossed or reached: 27.1.2020

6. Total positions

_____________________________________________________________________________
| | | % of voting | | |
| | % of voting |rights through | |Total number of|
| |rights attached|financial/other|Total of both | voting rights |
| |to shares (7.A)| instruments |in % (7.A + | of issuer |
|_____________|_______________|(7.B.1_+_7.B.2)|7.B)___________|_______________|
| Resulting | | | | |
|situation on | | | | |
| the date on | | | | |
| which | 4.08 % | 0.00 % | 4.08 %|1,469,770 |
| threshold | | | | |
|was crossed /| | | | |
|___reached___|_______________|_______________|_______________|_______________|
|Position of | | | | |
|previous | | | | |
|notification | | | | |
|(if | | | | |
|applicable)__|_______________|_______________|_______________|_______________|

Details
7. Notified details of the resulting situation:

______________________________________________________________________________
|A:_Voting_rights_attached_to_shares___________________________________________|
| |Number_of_voting_rights_________|%_of_voting_rights______________|
| | Direct |Indirect (Sec | Direct |Indirect (Sec |
|ISIN Code |(Sec 130 BörseG|133 BörseG |(Sec 130 BörseG|133 BörseG |
|____________|_____2018)_____|_____2018)______|_____2018)_____|_____2018)______|
|AT0000831706|_______________|__________60,000|_______________|__________4.08_%|
|SUBTOTAL_A__|__________________________60,000|__________________________4.08_%|

__________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 |
|BörseG_2018_______________________________________________________________|
| | | |Number of voting | |
| | | | rights that may | |
|Type of |Expiration Date| Exercise Period| be acquired if |% of voting|
|instrument| | |the instrument is|rights |
|__________|_______________|_________________|____exercised____|___________|
|__________|_______________|_________________|_________________|___________|
|__________________________|_____SUBTOTAL_B.1|_________________|___________|

________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 |
|BörseG_2018_____________________________________________________________|
| |Expiration|Exercise|Physical / Cash|Number of |% of voting|
|Type of |Date |Period |Settlement |voting rights|rights |
|instrument|__________|________|_______________|_____________|___________|
|__________|__________|________|_______________|_____________|___________|
|______________________________|_SUBTOTAL_B.2__|_____________|___________|

8. Information in relation to the person subject to the notification obligation:
Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

______________________________________________________________________________
| | | | | Financial/ | |
| | | Directly |Shares held | other |Total of both|
| No. | Name | controlled |directly (%)|instruments | (%) |
| | | by No. | | held | |
|____________|____________|____________|____________|directly_(%)|_____________|
|___________1|__Jan_Vedral|____________|______0.00_%|______0.00_%|_______0.00_%|
| | Conseq| | | | |
| 2| Investment| 1| 0.00 %| 0.00 %| 0.00 %|
| | Management,| | | | |
|____________|________a.s.|____________|____________|____________|_____________|
| | Conseq| | | | |
| 3| Penzijní| 2| 0.00 %| 0.00 %| 0.00 %|
| | spole¿nost,| | | | |
|____________|________a.s.|____________|____________|____________|_____________|
| | Conseq| | | | |
| | globální| | | | |
| 4| akciový| 3| 2.33 %| 0.00 %| 2.33 %|
| | úcastnický| | | | |
|____________|________fond|____________|____________|____________|_____________|
| 5| Conseq| | 0.00 %| 0.00 %| 0.00 %|
|____________|__Invest_Plc|____________|____________|____________|_____________|
| | Conseq| | | | |
| 6|Invest Akcie| 5| 1.75 %| 0.00 %| 1.75 %|
|____________|_Nové_Evropy|____________|____________|____________|_____________|

9. In case of proxy voting
Date of general meeting: –
Voting rights after general meeting: – is equivalent to – voting rights.

10. Other comments:
Shares are held by two investment funds managed by investment companies as stated above acting in concert.

end of announcement euro adhoc

issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English

Digital press kit: http://www.ots.at/pressemappe/31479/aom